Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 68

1.

Rat behavior and dopamine release are modulated by conspecific distress.

Lichtenberg NT, Lee B, Kashtelyan V, Chappa BS, Girma HT, Green EA, Kantor S, Lagowala DA, Myers MA, Potemri D, Pecukonis MG, Tesfay RT, Walters MS, Zhao AC, Blair RJR, Cheer JF, Roesch MR.

Elife. 2018 Nov 28;7. pii: e38090. doi: 10.7554/eLife.38090.

2.

Contributions of nucleus accumbens dopamine to cognitive flexibility.

Radke AK, Kocharian A, Covey DP, Lovinger DM, Cheer JF, Mateo Y, Holmes A.

Eur J Neurosci. 2018 Sep 15. doi: 10.1111/ejn.14152. [Epub ahead of print]

PMID:
30218623
3.

Activation of the mGlu1 metabotropic glutamate receptor has antipsychotic-like effects and is required for efficacy of M4 muscarinic receptor allosteric modulators.

Yohn SE, Foster DJ, Covey DP, Moehle MS, Galbraith J, Garcia-Barrantes PM, Cho HP, Bubser M, Blobaum AL, Joffe ME, Cheer JF, Jones CK, Lindsley CW, Conn PJ.

Mol Psychiatry. 2018 Aug 16. doi: 10.1038/s41380-018-0206-2. [Epub ahead of print]

PMID:
30116027
4.

Cannabinoid receptor-1 signaling contributions to sign-tracking and conditioned reinforcement in rats.

Bacharach SZ, Nasser HM, Zlebnik NE, Dantrassy HM, Kochli DE, Gyawali U, Cheer JF, Calu DJ.

Psychopharmacology (Berl). 2018 Oct;235(10):3031-3043. doi: 10.1007/s00213-018-4993-6. Epub 2018 Aug 14.

PMID:
30109373
5.

Inhibition of endocannabinoid degradation rectifies motivational and dopaminergic deficits in the Q175 mouse model of Huntington's disease.

Covey DP, Dantrassy HM, Yohn SE, Castro A, Conn PJ, Mateo Y, Cheer JF.

Neuropsychopharmacology. 2018 Sep;43(10):2056-2063. doi: 10.1038/s41386-018-0107-8. Epub 2018 Jun 1.

PMID:
29925886
6.

Phasic Dopamine Signals in the Nucleus Accumbens that Cause Active Avoidance Require Endocannabinoid Mobilization in the Midbrain.

Wenzel JM, Oleson EB, Gove WN, Cole AB, Gyawali U, Dantrassy HM, Bluett RJ, Dryanovski DI, Stuber GD, Deisseroth K, Mathur BN, Patel S, Lupica CR, Cheer JF.

Curr Biol. 2018 May 7;28(9):1392-1404.e5. doi: 10.1016/j.cub.2018.03.037. Epub 2018 Apr 19.

PMID:
29681476
7.

An Interaction between Serotonin Receptor Signaling and Dopamine Enhances Goal-Directed Vigor and Persistence in Mice.

Bailey MR, Goldman O, Bello EP, Chohan MO, Jeong N, Winiger V, Chun E, Schipani E, Kalmbach A, Cheer JF, Balsam PD, Simpson EH.

J Neurosci. 2018 Feb 28;38(9):2149-2162. doi: 10.1523/JNEUROSCI.2088-17.2018. Epub 2018 Jan 24.

8.

Endocannabinoid Actions on Cortical Terminals Orchestrate Local Modulation of Dopamine Release in the Nucleus Accumbens.

Mateo Y, Johnson KA, Covey DP, Atwood BK, Wang HL, Zhang S, Gildish I, Cachope R, Bellocchio L, Guzmán M, Morales M, Cheer JF, Lovinger DM.

Neuron. 2017 Dec 6;96(5):1112-1126.e5. doi: 10.1016/j.neuron.2017.11.012.

9.

A new dawn in cannabinoid neurobiology: The road from molecules to therapeutic discoveries.

Cheer JF, Hurd YL.

Neuropharmacology. 2017 Sep 15;124:1-2. doi: 10.1016/j.neuropharm.2017.07.004. Epub 2017 Jul 8. No abstract available.

PMID:
28694099
10.

Ensembles in medial and lateral orbitofrontal cortex construct cognitive maps emphasizing different features of the behavioral landscape.

Lopatina N, Sadacca BF, McDannald MA, Styer CV, Peterson JF, Cheer JF, Schoenbaum G.

Behav Neurosci. 2017 Jun;131(3):201-12. doi: 10.1037/bne0000195.

11.

Endocannabinoid modulation of dopamine neurotransmission.

Covey DP, Mateo Y, Sulzer D, Cheer JF, Lovinger DM.

Neuropharmacology. 2017 Sep 15;124:52-61. doi: 10.1016/j.neuropharm.2017.04.033. Epub 2017 Apr 25. Review.

12.

The endocannabinoid system as a target for novel anxiolytic drugs.

Patel S, Hill MN, Cheer JF, Wotjak CT, Holmes A.

Neurosci Biobehav Rev. 2017 May;76(Pt A):56-66. doi: 10.1016/j.neubiorev.2016.12.033. Review.

13.

Subsecond Sensory Modulation of Serotonin Levels in a Primary Sensory Area and Its Relation to Ongoing Communication Behavior in a Weakly Electric Fish.

Fotowat H, Harvey-Girard E, Cheer JF, Krahe R, Maler L.

eNeuro. 2016 Nov 2;3(5). pii: ENEURO.0115-16.2016. eCollection 2016 Sep-Oct.

14.

Chronic lithium treatment rectifies maladaptive dopamine release in the nucleus accumbens.

Can A, Frost DO, Cachope R, Cheer JF, Gould TD.

J Neurochem. 2016 Nov;139(4):576-585. doi: 10.1111/jnc.13769. Epub 2016 Oct 18.

15.

Drug-Induced Alterations of Endocannabinoid-Mediated Plasticity in Brain Reward Regions.

Zlebnik NE, Cheer JF.

J Neurosci. 2016 Oct 5;36(40):10230-10238. Review.

16.

Medial Orbitofrontal Neurons Preferentially Signal Cues Predicting Changes in Reward during Unblocking.

Lopatina N, McDannald MA, Styer CV, Peterson JF, Sadacca BF, Cheer JF, Schoenbaum G.

J Neurosci. 2016 Aug 10;36(32):8416-24. doi: 10.1523/JNEUROSCI.1101-16.2016.

17.

Effects of Ketamine and Ketamine Metabolites on Evoked Striatal Dopamine Release, Dopamine Receptors, and Monoamine Transporters.

Can A, Zanos P, Moaddel R, Kang HJ, Dossou KS, Wainer IW, Cheer JF, Frost DO, Huang XP, Gould TD.

J Pharmacol Exp Ther. 2016 Oct;359(1):159-70. doi: 10.1124/jpet.116.235838. Epub 2016 Jul 28.

18.

Subsecond Regulation of Synaptically Released Dopamine by COMT in the Olfactory Bulb.

Cockerham R, Liu S, Cachope R, Kiyokage E, Cheer JF, Shipley MT, Puche AC.

J Neurosci. 2016 Jul 20;36(29):7779-85. doi: 10.1523/JNEUROSCI.0658-16.2016.

19.

Endocannabinoid Regulation of Cocaine Reinforcement: an Upper or Downer?

Covey DP, Zlebnik NE, Cheer JF.

Neuropsychopharmacology. 2016 Aug;41(9):2189-91. doi: 10.1038/npp.2016.25. No abstract available.

20.

Supplemental Content

Loading ...
Support Center